February 10, 2021 Vancouver, British Columbia: Terra Nova Resources Inc. (CSE: TENO) (the “Company” or “Terra Nova”) is pleased to announce the appointment of a Program Development Manager within WellteQ, the acquisition target seeking imminent CSE listing by way of Reverse Takeover (RTO).
WellteQ, one of Asia Pacific’s most advanced digital health companies, is proud to announce the appointment of Ms Gretchen Masters as Program Development Manager. Ms Masters has recently departed nib, Australia’s third largest health insurer where she ran a team responsible for the development and delivery of Well with nib, a digital solution that is designed to motivate nib’s two million members to engage in healthier habits and decrease health risk.
“We're delighted to welcome Gretchen to our growing team. She introduces buy-side experience to guide exactly what our largest customers, insurance companies, are seeking. We have a policy to seek gold-plated minds and experience combinations and we are proud that our team now includes Gretchen.”
WellteQ CEO, Scott Montgomery shares, “We’re delighted to welcome Gretchen to our growing team. She introduces buy-side experience to guide exactly what our largest customers, insurance companies, are seeking. We have a policy to seek gold-plated minds and experience combinations and we are proud that our team now includes Gretchen.”
Ms Masters’ experience and objectives are based on a solid foundation of research and scientific evidence, design thinking and agile methodology. Masters has experience designing digital health programs, corporate stakeholder management and customer research, which remain at the core of WellteQ’s business.
Masters explains “My aim is to prevent preventable illness. As the world changes, it’s clear that this needs to be achieved via digital channels, which is why I’m thrilled to be working with WellteQ. Health and wellbeing programmes will incorporate educational content and the principles of behaviour change to genuinely drive healthy habits relating to nutrition, physical activity, sleep and mental wellbeing. These behaviour changes will be tracked and measured, demonstrating the related improvement in the health outcomes of WellteQ users.”
As previously announced, the Company has entered into definitive agreements to acquire all of the outstanding shares of WellteQ and CBDS. The proposed acquisition of WellteQ and CBDS (the “Proposed Transaction”) will constitute a “fundamental change” under the rules and policies of the Canadian Securities Exchange. Pursuant to the rules and policies of the CSE, it is expected that trading in the Company’s common shares will be halted and will remain halted until the completion of the Proposed Transaction or the provisions of the Company’s agreements to acquire WellteQ and CBDS Agreement are terminated. There can be no assurance that the Proposed Transaction will be completed on the terms proposed or at all.
wellteq Digital Health Inc. is a leading global provider of personalized digital health and wellness
solutions across the continuum of care.
To learn more, visit https://wellteq.co/
Download the wellteq Corporate Presentation:
https://wellteq.co/about/investors/
wellteq Investor Contact:
Glen Akselrod
Bristol Investor Relations
E: glen@bristolir.com
T: (905) 326-1888
Cautionary Note Regarding Forward-Looking Statements:
This news release contains information or statements that constitute “forward-looking statements.” Such forward looking statements
involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or
developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forwardlooking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified
by words such as “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or
that events or conditions “will,” “would,” “may,” “could” or “should” occur.
Forward looking information may include, without limitation, statements regarding the operations, business, financial condition, expected
financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of
Wellteq, and includes statements about, among other things, future developments and the future operations, strengths and strategies of
Wellteq. Forward-looking information is provided for the purpose of presenting information about management’s current expectations
and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These
statements should not be read as guarantees of future performance or results.
The forward-looking statements made in this news release are based on management’s assumptions and analysis and other factors that
may be drawn upon by management to form conclusions and make forecasts or projections, including management’s experience and
assessments of historical trends, current conditions and expected future developments. Although management believes that these
assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results
may differ materially from those projected in any forward-looking statements. Examples of risks and factors that could cause actual
results to materially differ from forward-looking statements may include: the timing and unpredictability of regulatory actions; regulatory,
legislative, legal or other developments with respect to its operations or business; limited marketing and sales capabilities; early stage of
the industry and product development; limited products; reliance on third parties; unfavourable publicity or consumer perception; general
economic conditions and financial markets; the impact of increasing competition; the loss of key management personnel; capital
requirements and liquidity; access to capital; the timing and amount of capital expenditures; the impact of COVID-19; shifts in the demand
for Wellteq’s products and the size of the market; patent law reform; patent litigation and intellectual property; conflicts of interest; and
general market and economic conditions.
The forward-looking information contained in this news release represents the expectations of Wellteq as of the date of this news release
and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and
should not rely upon this information as of any other date. Wellteq undertakes no obligation to update these forward-looking statements
in the event that management’s beliefs, estimates or opinions, or other factors, should change.
The CSE has neither approved nor disapproved the contents of this news release.